Physician profile
Fara Bellows
NPI 1083935118
$4,036.68
in general payments reported to CMS, 2019-2025
31 companies · $886 in 2025
The $886 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.81 · 2020: $116 · 2021: $617 · 2022: $61.63 · 2023: $579 · 2024: $1,754 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,451 · Travel and Lodging: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,451.41 |
| Travel and Lodging | $767.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,118.99 | 2024 | |
| Boston Scientific Corporation | $610.82 | 2019-2025 | Lumenis Pulse 50h, Solyx Sis System, General - Female Sui |
| Teleflex LLC | $451.38 | 2021-2024 | Urolift |
| Sumitomo Pharma America, INC. | $254.22 | 2024-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $230.68 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $190.64 | 2021-2024 | Axonics, Bulkamid |
| Myovant Sciences INC. | $124.54 | 2021 | |
| Foundation Medicine, INC. | $119.73 | 2023 | |
| Edap Technomed INC | $99.00 | 2024 | |
| Medtronic USA, INC. | $97.42 | 2020 | |
| Dentsply Ih Ab | $73.93 | 2023-2025 | Lofric, Lofric |
| Urogen Pharma, INC. | $69.60 | 2023 | Jelmyto |
| Janssen Biotech, INC. | $69.30 | 2025 | Carvykti, Rybrevant |
| Endo Pharmaceuticals INC. | $58.07 | 2021 | |
| Endo USA, INC. | $51.75 | 2025 | Xiaflex, Aveed |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $48.57 | 2021-2022 | |
| Medtronic, INC. | $47.23 | 2021-2023 | Interstim |
| Astrazeneca Pharmaceuticals Lp | $45.63 | 2022 | |
| Merck Sharp & Dohme LLC | $34.26 | 2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $32.91 | 2021 | |
| Olympus America INC. | $28.71 | 2024 | Itind System |
| Calyxo, INC. | $26.75 | 2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $25.32 | 2025 | |
| Karl Storz Endoscopy-America | $22.74 | 2025 | |
| Clarus Therapeutics INC. | $20.24 | 2021 | |
| Neotract INC. | $18.92 | 2020 | |
| Cook Medical LLC | $15.94 | 2025 | Cook |
| Pfizer INC. | $13.22 | 2021 | |
| Antares Pharma, INC. | $12.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.05 | 2021 | |
| Davol INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fara Bellows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.